Pramlintide as an Adjunct to Insulin Therapy Improves Long-Term Glycemic and Weight Control in Patients With Type 2 Diabetes - Concepedia

Concepedia

Publication | Open Access

Pramlintide as an Adjunct to Insulin Therapy Improves Long-Term Glycemic and Weight Control in Patients With Type 2 Diabetes

DOI Full Paper Access

299

Citations

25

References

2003

Year

Priscilla Hollander, Philip T. Levy, Mark Fineman, David Maggs, Larry Z. Shen, S. Strobel, Christian Weyer, Orville Kolterman

Abstract

Mealtime amylin replacement with pramlintide 120 microg BID, as an adjunct to insulin therapy, improves long-term glycemic and weight control in patients with type 2 diabetes.

References

	Year	Citations

Page 1